Innovation
In this conversation, Mark Taylor, M.D., surgical director for surgical operations at Cleveland Clinic, discusses the health system's ongoing IV fluid conservation strategies and the importance of constant and targeted communication during supply chain shortages.
In this conversation, James Liggins, Jr., senior counsel at Warner Norcross + Judd, and vice chair of the board of directors at Bronson Healthcare, discusses his work developing a tool for board members that allows them to effectively understand and address areas of concern for their organizations.
There are a number of factors that may complicate recovery from open-heart surgery, but for female patients, bra size and fit shouldn’t be one of them.
In this conversation, Jefferson Health's Cara Martino, DNP, R.N., enterprise vice president of clinical improvement and transformation, and Trish Henwood, M.D., executive vice president and chief clinical officer, discuss the organization's ever-growing patient population.
Coronary artery bypass surgery is a major ordeal — open-heart surgery lasting three to six hours, a stay in the hospital that could last up to a week, then six to 12 weeks of recovery. For one patient at Doctors Medical Center (DMC) in Modesto, Calif., coronary artery bypass was much simpler…
AI clinical documentation tools — tools that use artificial intelligence to securely summarize medical information from spoken conversations — are becoming widely recognized as resources that ease clinicians’ workloads so they can spend more time with patients.
Physicians at Massachusetts General Hospital, a founding member of Mass General Brigham, have done groundbreaking proton therapy research, studying the best use of this therapy for clinical care.
The first-time integration of two innovative technologies is providing immediate benefits to Wyoming cardiac patients.
In this Leadership Dialogue conversation, Steven Diaz, M.D., chief medical officer at MaineGeneral Health and board member at the ºÚÁÏÕýÄÜÁ¿ Association, discusses his passion for patient safety, how his organization meets quality care for its community, and how AI could potentially be…
For years, the first-line treatment for atrial fibrillation, or A-fib, has been blood thinners. A-fib, which is a cardiac rhythm abnormality, can lead to other health complications, including strokes — it’s estimated that 90% of all strokes happen in patients who have A-fib.